New therapeutic options in the management of COPD &ndash; focus on roflumilast

New therapeutic options in the management of COPD &ndash; focus on roflumilast

Sabina Antonela AntoniuUniversity of Medicine and Pharmacy, Pulmonary Disease Division, Pulmonary Disease University Hospital, Iasi, RomaniaAbstract: In chronic obstructive pulmonary disease (COPD) the inflammation occurring in the airways and in other lung tissues is complex and is orchestrated by...

Full description

Bibliographic Details
Main Author:	Sabina Antonela Antoniu
Format:	Article
Language:	English
Published:	Dove Medical Press 2011-02-01
Series:	International Journal of COPD
Online Access:	http://www.dovepress.com/new-therapeutic-options-in-the-management-of-copd-ndash-focus-on-roflu-a6377

Similar Items

Pharmacological mechanism of roflumilast in the treatment of asthma–COPD overlap
by: Zhang X, et al.
Published: (2018-08-01)

The use of roflumilast in COPD: a review
by: Andrea Zanini, et al.
Published: (2015-08-01)

Roflumilast in COPD: a Brazilian perspective
by: Stirbulov R, et al.
Published: (2015-09-01)

Roflumilast: the fourth Mousquetaire in COPD pharmacological treatment
by: Bruno Balbi
Published: (2015-08-01)

Vulnerable COPD patients with comorbidities: the role of roflumilast
by: Lipari M, et al.
Published: (2014-11-01)

New treatment options in the management of IBD &ndash; focus on colony stimulating factors
by: Josu&eacute; Barahona-Garrido, et al.
Published: (2008-09-01)

New treatment options for lupus &ndash; a focus on belimumab
by: Chiche L, et al.
Published: (2012-01-01)

Roflumilast: a review of its use in the treatment of COPD
by: Wedzicha JA, et al.
Published: (2016-01-01)

Does roflumilast induce phagocytic activity in COPD patients?
by: Ghosh B, et al.
Published: (2015-09-01)

Two cases of COPD benefitting from therapy with roflumilast
by: Chiara Francesca Carraro
Published: (2015-08-01)

Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD
by: Mark A Giembycz, et al.
Published: (2010-07-01)

Emerging Therapeutic Options for the Management of COPD
by: Debra J. Reid, et al.
Published: (2013-04-01)

Emerging Therapeutic Options for the Management of COPD
by: Debra J. Reid, et al.
Published: (2013-01-01)

Roflumilast is effective in reducing COPD related exacerbations and improving CAT score
by: Biagio Polla
Published: (2015-08-01)

Roflumilast is safe and effective in improving symptoms and lung function in severe COPD
by: Matteo Bonini, et al.
Published: (2015-08-01)

Adherence to roflumilast under dose-escalation strategy in Korean patients with COPD
by: Park TS, et al.
Published: (2019-04-01)

Roflumilast: A Review of Chronic Obstructive Pulmonary Disease (COPD) Treatment
by: Ita Octafia, et al.
Published: (2021-01-01)

Therapeutic options in the management of acromegaly: focus on lanreotide Autogel&reg;
by: Ferdin, et al.
Published: (2008-09-01)

Epigenetic Targets for Therapeutic Approaches in COPD and Asthma. Nutrigenomics &ndash; Possible or Illusive
by: Radostina V. Cherneva, et al.
Published: (2019-09-01)

Roflumilast, a Novel Phosphodiesterase 4 Inhibitor, for COPD Patients with a History of Exacerbations
by: Stephen K. Field
Published: (2011-01-01)

Glucocorticoid Receptor α Mediates Roflumilast’s Ability to Restore Dexamethasone Sensitivity in COPD
by: Reddy AT, et al.
Published: (2020-01-01)

Potential treatment benefits and safety of roflumilast in COPD: a systematic review and meta-analysis
by: Yuan L, et al.
Published: (2016-06-01)

Roflumilast, a Novel Phosphodiesterase 4 Inhibitor, for COPD Patients with a History of Exacerbations
by: Stephen K. Field
Published: (2011-10-01)

A Way to Increase the Bioaccesibility and Photostability of Roflumilast, a COPD Treatment, by Cyclodextrin Monomers
by: Adrián Matencio, et al.
Published: (2019-05-01)

Use of a 4-week up-titration regimen of roflumilast in patients with severe COPD
by: Watz H, et al.
Published: (2018-03-01)

Significant gas-exchange improvements reported after roflumilast in two cases of severe COPD
by: Bruno Sposato
Published: (2015-08-01)

Frailty, a Dimension of Impaired Functional Status in Advanced COPD: Utility and Clinical Applicability
by: Sabina Antonela Antoniu, et al.
Published: (2021-05-01)

Preventing and managing exacerbations in COPD &ndash; critical appraisal of the role of tiotropium
by: Donald P Tashkin
Published: (2010-02-01)

Update on treatment options for Lambert&ndash;Eaton myasthenic syndrome: focus on use of amifampridine
by: Lindquist S, et al.
Published: (2011-05-01)

Erratum for “Roflumilast, a Novel Phosphodiesterase 4 Inhibitor, for COPD Patients with a History of Exacerbations”
by: Stephen K. Field
Published: (2012-01-01)

Erratum for "Roflumilast, a Novel Phosphodiesterase 4 Inhibitor, for COPD Patients with a History of Exacerbations"
by: Stephen K. Field
Published: (2012-08-01)

Cost-effectiveness of roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland
by: Samyshkin Y, et al.
Published: (2013-01-01)

Reduction of exacerbations by the PDE4 inhibitor roflumilast - the importance of defining different subsets of patients with COPD
by: Goehring Udo M, et al.
Published: (2011-01-01)

Roflumilast, a phosphodiesterase-4 inhibitor, induces phagocytic activity in Greek COPD patients
by: Porpodis K, et al.
Published: (2015-06-01)

Emerging treatments in the management of schizophrenia &ndash; focus on sertindole
by: Maria Rosaria A Muscatello, et al.
Published: (2010-08-01)

A case report of roflumilast in an elderly COPD patient: improving exercise capacity to improve quality of life
by: Daniela Parola, et al.
Published: (2015-08-01)

Patient education programs&nbsp;&ndash; can they improve outcomes in COPD?
by: Melanie Harris, et al.
Published: (2008-05-01)

Gynecomastia &ndash; evaluation and current treatment options
by: Johnson RE, et al.
Published: (2011-03-01)

Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec&reg;, Gleevec&trade;)
by: Martin Henkes, et al.
Published: (2008-03-01)

Emerging options for the treatment of melanoma – focus on ipilimumab
by: Roddie C, et al.
Published: (2014-03-01)